IRadimed Corporation

NASDAQ: IRMD · Real-Time Price · USD
51.85
-0.82 (-1.56%)
At close: May 09, 2025, 3:59 PM
51.86
0.02%
After-hours: May 09, 2025, 04:05 PM EDT

Company Description

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.

It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.

The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.

It serves hospitals, acute care facilities, and outpatient imaging centers.

The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors.

IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

IRadimed Corporation
IRadimed Corporation logo
Country United States
IPO Date Jul 16, 2014
Industry Medical - Devices
Sector Healthcare
Employees 160
CEO Randy Waddell

Contact Details

Address:
1025 Willa Springs Drive
Winter Springs, Florida
United States
Website https://www.iradimed.com

Stock Details

Ticker Symbol IRMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001325618
CUSIP Number 46266A109
ISIN Number US46266A1097
Employer ID 73-1408526
SIC Code 3841

Key Executives

Name Position
Chris Williamson Executive Vice President of Continuous Improvement & Information Technology
Lynn Neuhardt Vice President of Research & Development
Matt Garner Controller
Randy Waddell Vice President of Worldwide Sales & Marketing

Latest SEC Filings

Date Type Title
May 05, 2025 10-Q Quarterly Report
May 05, 2025 8-K Current Report
Apr 30, 2025 ARS Filing
Apr 30, 2025 DEF 14A Filing
Apr 29, 2025 SCHEDULE 13G/A [Amend] Filing
Apr 07, 2025 4/A [Amend] Filing
Apr 04, 2025 4/A [Amend] Filing
Apr 04, 2025 4 Filing
Mar 06, 2025 10-K Annual Report
Feb 13, 2025 SCHEDULE 13G Filing